PAR paradigm biopharmaceuticals limited..

Ann: CHIKV study data published in Peer-Reviewed Journal, page-19

  1. 86 Posts.
    lightbulb Created with Sketch. 21
    Interestingly enough, iPPS being an anti-inflammatory, you would think that it would have negative impacts on healing and repair, not aid it with increasing regenerating myocytes to a damaged/infected area... This sounds positive but backwards as far as science goes so I may have to dig a little deeper into that comment. Exciting if this really happens!

    Inflammation is the first stage of the healing process and taking anti-inflammatories can actually inhibit the healing time of an injury or illness. As iPPS has anti-inflammatory properties I was worried that this would rule out people from taking it who were going through a healing process. I also wonder any contraindications with the use of iPPS or negative drug interactions that would preclude it from being used with other medications. The type of person likely to have OA would be over 60/70 years old and quite often would be on multiple drugs at this stage for management of a whole lot of other conditions
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
40.5¢
Change
-0.005(1.22%)
Mkt cap ! $160.9M
Open High Low Value Volume
40.0¢ 41.0¢ 40.0¢ $87.37K 216.3K

Buyers (Bids)

No. Vol. Price($)
4 13980 40.5¢
 

Sellers (Offers)

Price($) Vol. No.
41.0¢ 3900 2
View Market Depth
Last trade - 11.45am 18/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.